Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal response.
Frontline Gastroenterol
; 11(3): 188-193, 2020.
Article
in En
| MEDLINE
| ID: mdl-32419909
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Frontline Gastroenterol
Year:
2020
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United kingdom